Distribution of mirtazapine (Remeron®) in thirteen postmortem cases

Journal of Analytical Toxicology

Volumn 23, Issue 6, 1999, Pages 544-548

  Anderson, Daniel T ^a   Fritz, Kristina L ^a   Muto, Joseph J ^a  

^a Los Angeles County Department of Coroner   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; CLONAZEPAM; DIPHENHYDRAMINE; FLUVOXAMINE; GABAPENTIN; HYDROCODONE; IBUPROFEN; LORAZEPAM; METHADONE; MIRTAZAPINE; NADOLOL; NORTRIPTYLINE; OLANZAPINE; OXAZEPAM; PAROXETINE; RISPERIDONE; TRAZODONE; TRIAMTERENE; VALPROIC ACID;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TISSUE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

EID: 0032826802     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/23.6.544     Document Type: Article

References (7)

1. Mirtazapine approved for depression. Med. Sci. Bull.19(2): 1 (1996).
2. C.J. Timmer, J.E. Paanakker, and H.J.M. Van Hal. Pharmacokinetics of mirtazapine from orally administered tablets: influence of gender, age and treatment regimen. Hum. Psychopharmacol. 11: 497-509 (1996).
3. Remeron. Physicians' Desk Reference, 52nd ed. Medical Economics, Montvale, NJ, 1998, p 1956.
4. C.J. Timmer, J.E. Paanakker, and M. Vrijmode-de Vries. Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations. Pharm. Res. 14(1): 98-102 (1997).
5. E. Lavins, H. Wogoman, and A. Jenkins. Mirtazapine (Remeron®): detection of a new antidepressant in postmortem cases. Poster Presentation, SOFT Annual Meeting, Albuquerque, NM, 1998.
6. A.W. Gerritsen. Safety in overdose of mirtazapine: a case report. J. Clin. Psychiatry 58(6): 271 (1997).
7. T. de Boer. The pharmacological profile of mirtazapine. J. Clin. Psychiatry 57(suppl 4): 19-25 (1996).